Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Tablets × 90 days × Clear all

Sponsor

Conditions

TP53 Y220C Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Localized Prostate Cancer 1 Leiomyosarcoma 1 Head and Neck Neoplasms 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Deglutition Disorders 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1

Interventions

Bevacizumab 33 atezolizumab 22 durvalumab 20 lenvatinib 19 Specimen Handling 18 Nivolumab 17 Magnetic Resonance Spectroscopy 16 pembrolizumab 15 tremelimumab 12 Radiosurgery 10 Ipilimumab 9 tislelizumab 8 sintilimab 8 regorafenib 8 Sorafenib 7 Immunoglobulin G 7 X-Rays 6 Disulfides 6 Cyclophosphamide 6 fludarabine 5 Biopsy 5 cabozantinib 4 Blood Specimen Collection 4 Radiotherapy 3 Radiation 3 Oxaliplatin 3 Immunotherapy 3 Immune Checkpoint Inhibitors 3 Fluorodeoxyglucose F18 3 Ethiodized Oil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡